Results 11 to 20 of about 97,672 (218)

ICSI Cycles Using Motile Sperm from Fresh Ejaculate in Cryptozoospermic Patients and the Extremely Severe Oligospermia Patients Yield Similar Reproductive Outcome

open access: yesJournal of Urological Surgery, 2022
Objective:In this retrospective study, we analyzed the in vitro fertilization (IVF) clinical and laboratory outcome of cryptozoospermia cases compared to the extremely severe oligospermia cases in a single IVF center.Materials and Methods:All the IVF ...
Mustafa Albayrak, Mehmet Ali Akman
doaj   +1 more source

Different doses of recombinant FSH and determining parameters of oxidative stress [PDF]

open access: yesJournal of Medical Biochemistry
Background: This study aimed to examine if there is a connection between recombinant FSH dose and OS parameters in serum and the impact on IVF outcome. Methods: This study consisted of 101 participants that went through IVF procedures.
Tulić Lidija   +5 more
doaj   +1 more source

Clinical Outcomes of ICSI Using Advanced Quantitative Phase Microscopy

open access: yesBioengineering
This study evaluated the clinical outcomes associated with quantitative phase microscopy (QPM), an advanced 3D morphological sperm analysis technique using a virtual, stained model developed in our facility that indicates whether the inspected sperm ...
Roni Rahav-Koren   +7 more
doaj   +1 more source

Relationship between Endometrial Thickness and In Vitro Fertilization-Intracytoplasmic Sperm Injection Outcome [PDF]

open access: yesInternational Journal of Fertility and Sterility, 2013
Background: This study assessed the relationship between endometrial thickness on day of human chorionic gonadotropin (hCG) administration and in vitro fertilizationintracytoplasmic sperm injection (IVF-ICSI).
Turgut Aydin   +2 more
doaj  

Reproductive Axis Recovery Post-Ovarian Stimulation and Gonadotropin-Releasing Hormone Agonist (GnRH-a) Trigger: Observational Case Series

open access: yesReproductive Medicine
Background: Following gonadotropin-releasing hormone (GnRH) agonist trigger and “freeze all” in order to prevent ovarian hyper-stimulation syndrome (OHSS), patients are usually anxious to continue immediately with a frozen embryo transfer (FET ...
Tatyana Breizman, Shahar Kol
doaj   +1 more source

Oxidative stress markers in GnRH agonist and antagonist protocols in IVF [PDF]

open access: yesJournal of Medical Biochemistry, 2017
Background: Our aim was to study the effect of GnRH agonist and antagonist protocols of ovarian stimulation on oxidative stress parameters in serum and the influence of oxidative stress parameters change on the outcome of IVF cycles.
Tulić Lidija   +5 more
doaj  

Association of the Serum Folate and Total Calcium and Magnesium Levels Before Ovarian Stimulation With Outcomes of Fresh In Vitro Fertilization Cycles in Normogonadotropic Women

open access: yesFrontiers in Endocrinology, 2022
BackgroundWomen of reproductive age are recommended to consume folic acid and other supplements before conception and during pregnancy. We aimed to investigate the association of the serum folate and total magnesium (Mg) and calcium (Ca) levels before ...
Mikhail Polzikov   +12 more
doaj   +1 more source

Correlation of progesterone levels on the day of oocyte retrieval with basal hormonal status and the outcome of ART

open access: yesScientific Reports, 2020
This study aimed to assess whether basal hormonal levels can predict the levels of progesterone (P4) on the day of oocyte retrieval (OR) and examine the impact of P4 levels on the day of OR on the outcome of assisted reproduction.
L. Tulic   +6 more
doaj   +1 more source

Perinatal Outcomes of Singleton, Twin and Triplet Gestations after Oocyte Donation: A Retrospective, Population-Based Cohort Analysis

open access: yesChildren
Background/Objectives: Although high live birth rates are associated with oocyte donation (OD), these pregnancies are associated with increased obstetric and perinatal risks.
Or Eliner   +6 more
doaj   +1 more source

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy